Zentalis Pharmaceuticals (ZNTL) Accounts Payables (2019 - 2026)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Accounts Payables of $7.4 million for Q1 2026, down 5.03% year-over-year from $7.8 million in Q1 2025, and up 2.36% quarter-over-quarter from $7.2 million in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) Accounts Payables (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' Accounts Payables history runs 8 years deep, the most recent figure standing at $7.4 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 5.03% year-over-year to $7.4 million; the TTM figure through Mar 2026 stood at $7.4 million (down 5.03% YoY), while the FY2025 annual figure was $7.2 million, down 3.09% from the prior year.
- Accounts Payables for Q1 2026 stood at $7.4 million, up from $7.2 million in the prior quarter.
- The five-year high for Accounts Payables was $20.4 million in Q2 2024, with the low at $3.7 million in Q2 2025.
- The 5-year median for Accounts Payables is $10.5 million (2024), against an average of $10.6 million.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables soared 66.11% in 2024, then plunged 81.81% in 2025.
- Zentalis Pharmaceuticals' Accounts Payables stood at $11.2 million in 2022, then jumped by 32.71% to $14.9 million in 2023, then slumped by 50.17% to $7.4 million in 2024, then declined by 3.09% to $7.2 million in 2025, then climbed by 2.36% to $7.4 million in 2026.
- Business Quant data shows ZNTL's Accounts Payables at $7.4 million in Q1 2026, $7.2 million in Q4 2025, and $7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Zentalis Pharmaceuticals | 255.14 Mn | 255.14 Mn | - | 8.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.14 Mn |
| Mar 31, 2026 | 7.38 Mn |
| Dec 31, 2025 | 7.21 Mn |
| Sep 30, 2025 | 7.03 Mn |
| Jun 30, 2025 | 3.72 Mn |
| Mar 31, 2025 | 7.77 Mn |
| Dec 31, 2024 | 7.44 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | 20.44 Mn |
| Mar 31, 2024 | 10.50 Mn |
| Dec 31, 2023 | 14.93 Mn |
| Sep 30, 2023 | 14.26 Mn |
| Jun 30, 2023 | 12.31 Mn |
| Mar 31, 2023 | 12.82 Mn |
| Dec 31, 2022 | 11.25 Mn |
| Sep 30, 2022 | 9.82 Mn |
| Jun 30, 2022 | 12.04 Mn |
| Mar 31, 2022 | 13.16 Mn |
| Dec 31, 2021 | 11.59 Mn |
| Sep 30, 2021 | 8.05 Mn |